Repligen (RGEN) Equity Average (2011 - 2026)

Repligen (RGEN) has 16 years of Equity Average data on file, last reported at $2.1 billion in Q1 2026.

• Quarterly Equity Average rose 6.4% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 6.4% YoY) and the FY2025 annual result came in at $2.0 billion, up 3.59% from the prior year.
• Equity Average rose to $2.1 billion in Q1 2026 per RGEN's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Equity Average topped out at $2.1 billion in Q1 2026 and bottomed at $1.8 billion in Q1 2022.
• The 5-year median for Equity Average is $2.0 billion (2023), against an average of $2.0 billion.
• The widest annual swing landed in 2022, when Equity Average gained 13.97%; it then advanced 0.71% in 2025.
• Tracing RGEN's Equity Average over 5 years: stood at $1.9 billion in 2022, then increased by 5.15% to $2.0 billion in 2023, then climbed by 1.29% to $2.0 billion in 2024, then climbed by 5.01% to $2.1 billion in 2025, then gained by 0.53% to $2.1 billion in 2026.
• Per Business Quant, the three latest RGEN Equity Average figures stand at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025).

Peer Comparison